Core Insights - The "light medical beauty" market in China is experiencing rapid growth, with user numbers expected to reach 31.05 million by 2025 and the market size projected to exceed 300 billion yuan by 2026 [2] - "Light medical beauty" refers to non-surgical cosmetic procedures, which are characterized by flexibility, minimal trauma, short recovery times, and low risks, yet still fall under medical practices [2] - There is a concerning trend of unregulated training institutions offering quick courses that promise to teach "light medical beauty" techniques in just a few days, often without proper medical qualifications [3][4][7] Market Growth - The user base for "light medical beauty" is continuously expanding, contributing to the overall market growth [2] - The market is expected to surpass 300 billion yuan by 2026, indicating a significant opportunity for investment and development in this sector [2] Training Institutions - Numerous training institutions are advertising short courses that claim to enable individuals with no medical background to perform "light medical beauty" procedures [3][4] - These institutions often promote a "quick and easy" approach to learning, with some courses lasting only three days and covering various techniques [4][6] - Many of these institutions provide certificates that lack proper accreditation, raising concerns about the legitimacy of the training [7] Employment Opportunities - Graduates from these training programs are often encouraged to work as beauty consultants or to refer clients to medical institutions, creating a potential gray market for medical referrals [9] - The training institutions promote a model where individuals can earn significant income through client referrals, even if they do not perform the procedures themselves [9][10] Regulatory Concerns - There is a lack of regulatory oversight in the "light medical beauty" sector, with many practitioners operating without the necessary medical qualifications [8] - Experts emphasize that individuals performing "light medical beauty" procedures should possess medical licenses and be registered with health authorities [8]

Summary of Medical Aesthetics Industry Conference Call Industry Overview - The medical aesthetics industry is experiencing a slowdown in overall revenue growth, with August showing a 4% increase, influenced by a rise in non-surgical procedures and price transparency leading to a significant drop in average transaction value [1][3] - The average transaction value in July decreased by 5% year-on-year to approximately 3,300 RMB, marking the lowest in recent years. Although it slightly rebounded to around 3,600 RMB in August, it remains below last year's levels [1][4] Key Insights - Major industry players such as Langzi, Yixin, and Liga are facing disappointing revenue growth, with Yixin's retail sales remaining flat in July and August, and some months even showing declines [1][6] - The decline in average transaction value is attributed to increased price transparency, a higher proportion of non-surgical light medical aesthetics projects, and price wars initiated by platforms like Xinyang, which offer low-priced services [1][7] - Medical aesthetics institutions are actively expanding their light medical aesthetics sub-brands, focusing on skin light therapy, injections, and minimally invasive procedures. These smaller stores (500-1,000 square meters) are expanding slowly (3-5 new stores per year) but are expected to be a key growth area due to lower investment and easier scalability [1][9] Operational Differences - Traditional large medical aesthetics institutions and light medical aesthetics stores differ significantly in terms of investment, size, location, revenue, and return cycles. Light medical aesthetics stores require lower initial investments (5-6 million RMB) and have shorter return periods (6 months to break even, 8-10 months to profitability) but operate at lower profit margins [1][10][11] Market Trends - The high-end imported hyaluronic acid products like Juvederm and Restylane are seeing declining sales, with institutions opting for OEM products to reduce procurement costs. Newer domestic products like Gege Needle and Bobo Needle are performing well, compensating for the price drops of traditional brands [1][4][16][17] - The overall market for regenerative collagen products is growing, with Shuyancui emerging as a new growth point, driving market development despite some traditional products experiencing declines [1][19][20] Future Outlook - The industry anticipates continued declines in average transaction value and sluggish revenue growth. However, positive customer traffic growth is expected, prompting institutions to implement more promotional activities and focus on high-margin product lines [1][8] - The medical aesthetics sector typically sees a peak in September and October, with a projected 15% year-on-year growth target for September 2025. Operators plan to boost revenue through repeat purchases and promotional activities [1][15] Product Performance - The sales performance of core products in July and August indicates a decline in high-end imported hyaluronic acid sales, while new injection products are gaining traction. For instance, the sales of the HiTi series from Aimeike dropped significantly, while new products like Gege Needle and Bobo Needle are seeing increased usage [1][18][21] - The overall growth rate for injection collagen products is around 17%, with specific products like Wei Yimei showing a remarkable 45% increase compared to the previous year [1][21] Pricing and Cost Dynamics - Upstream manufacturers have reduced ex-factory prices by approximately 20%-30%, impacting the competitive landscape and prompting institutions to adapt by switching brands to maintain competitiveness [1][26]

Core Viewpoint - The article explores the psychological and financial implications of cosmetic procedures, highlighting the shift from rational decision-making to compulsive behavior in the pursuit of beauty, and the resulting anxiety and dissatisfaction that can arise from such choices [1][19][32]. Group 1: Personal Experience with Cosmetic Procedures - The subject, Xiaoman, has been engaged in cosmetic procedures for six years, starting with a focus on her nose due to childhood trauma [3][4]. - Initially, Xiaoman was rational in her choices, carefully selecting materials and practitioners, and adhering to a budget [7][8]. - The rise of "light medical beauty" has made non-invasive procedures more popular, surpassing traditional surgical options in market value since 2022 [10]. Group 2: Psychological Impact and Behavioral Changes - Xiaoman's experience reflects a broader trend where cosmetic procedures become a coping mechanism for personal crises, leading to excessive spending and a loss of control [13][19]. - After a breakup and increased work stress, Xiaoman's rational approach deteriorated, resulting in impulsive decisions regarding cosmetic treatments, leading to significant financial expenditure [17][18]. - The article discusses the concept of "spiritual essence," suggesting that while individuals may enhance their appearance, they risk losing their unique qualities [21][23]. Group 3: Industry Dynamics and Consumer Behavior - The cosmetic industry has shifted from exploiting information asymmetry to creating a cycle of anxiety and dependency on procedures [27][34]. - Consumers are becoming more informed and discerning, often researching specific treatments and practitioners before making decisions, which has led to a decrease in prices for certain procedures [26]. - The industry's focus on enhancing beauty standards perpetuates a cycle of demand, where individuals feel compelled to continuously invest in their appearance to meet societal expectations [35][36].

Investment Rating - The report assigns an "Accumulate" rating for the company, marking its first coverage [2]. Core Insights - In Q2 2025, the company's beauty treatment revenue exceeded guidance, with over 70% of new customers acquired through private channels and referrals [5]. - The company reported total revenue of 378.7 million yuan, a year-on-year decrease of 7.0%, and a net loss of 36 million yuan compared to a net profit of 18.9 million yuan in the same period last year [5]. - The beauty treatment service revenue reached 144.4 million yuan, surpassing the previous guidance of 120-140 million yuan, with a year-on-year growth of 426.1% driven by the expansion of beauty centers [5]. - The company anticipates Q3 2025 beauty treatment service revenue to be between 150-170 million yuan, representing a year-on-year growth of 230.5% to 274.6% [5]. - The company plans to expand its beauty center network to 50 locations by the end of the year, with over 70% of new customers coming from private channels and referrals, resulting in a low customer acquisition cost [5]. Financial Summary - The company forecasts revenues of 1.567 billion yuan, 2.751 billion yuan, and 4.366 billion yuan for 2025, 2026, and 2027 respectively, with year-on-year growth rates of 7%, 76%, and 59% [7]. - The projected net profit for 2025 is a loss of 148 million yuan, followed by profits of 36 million yuan and 134 million yuan in 2026 and 2027, reflecting year-on-year growth rates of 75% and 124% [7]. - The report indicates a significant improvement in gross margin for the beauty treatment business, reaching 24.25% in Q2 2025, an increase of 5.5 percentage points quarter-on-quarter [5].

Summary of the Conference Call Industry Overview - The light medical beauty industry is transitioning from reliance on high-priced projects and well-known doctors to standardized, cost-effective services. New Oxygen focuses on dermatology and small store layouts to meet consumer demands for transparency in product ingredients and pricing [2][4][18]. - The competition in the upstream product market for medical beauty is intensifying, with a significant increase in the issuance of three types of certificates in China. It is expected that by 2026, more companies will launch alternative products, breaking the monopoly of a few high-priced products and leading to market scaling [2][6][7]. Company Strategy and Operations - Traditional medical beauty institutions face high marketing costs and limited profit margins. New Oxygen aims to improve profit margins by controlling marketing costs, optimizing the supply chain, and developing proprietary products. The company is also exploring a model of self-operated small clinics [2][8][9]. - The chain rate in the light medical beauty industry is expected to increase, but it requires the provision of standardized treatments and high cost-performance services. New Oxygen implements a hard discount model to maintain profit margins while offering cost-effective services [2][10]. - The operational efficiency of chain clinics is influenced by scale, density, and efficiency. New Oxygen adopts a strategy that balances breadth and depth, focusing on high-density layouts in key cities to highlight chain advantages and improve overall efficiency [2][11]. Market Dynamics - The Chinese medical beauty market has developed rapidly over the past few years, but the industry chain structure still leans towards a seller's market with low chain rates. New Oxygen recognizes the challenges and pain points in the development of medical beauty chains and plans to leverage its advantages to achieve growth [3][8]. - The rise of regenerative products like water light needles and botulinum toxin has increased the proportion of dermatology projects, which are characterized by high frequency, low risk, and suitability for small chain stores [4][5]. Financial Performance and Projections - Traditional medical beauty institutions have low profit margins, with some large institutions only achieving around 3% to 5%. Marketing costs account for 30% to 50%, along with 20% to 30% for product costs. New Oxygen aims to control marketing costs within 10% and reduce product costs through its supply chain [8][9][22]. - Currently, the net profit margin for New Oxygen's stores is approximately 10% to 15%. In the next two to three years, as the proportion of proprietary products increases, the company expects the net profit margin to rise to 15% or even 20% [22]. Customer Retention and Cost Management - New Oxygen's model leans towards benefiting consumers and achieving equity in medical beauty services. The company employs various strategies to enhance customer retention and meet the needs of price-sensitive consumers, including membership operations, promotional activities, and community engagement [18][19]. - The company maintains a cost advantage in customer acquisition primarily through user referrals and private domain operations, which account for nearly 70% of its customer acquisition strategy [21]. Future Outlook - The light medical beauty industry is naturally suited for chain penetration due to its high standardization. New Oxygen plans to expand its presence in key cities with high-density layouts to leverage chain advantages [10][11]. - The company is also testing different site selection strategies for new clinics, focusing on core business districts and popular shopping centers to optimize overall operational effectiveness [14][16]. Conclusion - New Oxygen is strategically positioned to capitalize on the evolving landscape of the light medical beauty industry by focusing on cost-effective services, optimizing supply chains, and enhancing customer engagement. The company's proactive approach to market dynamics and operational efficiency is expected to drive future growth and profitability [2][10][21].

Core Viewpoint - The company, Xinyang (SY.US), experienced a significant stock increase of 9.43%, closing at $4.06, with a total market capitalization of $403 million. The Q2 2025 financial report indicates robust growth in the company's revenue, particularly in its offline light medical beauty segment, which has become the largest revenue source for the company [1]. Financial Performance - In Q2 2025, the company achieved total revenue of 379 million yuan [1]. - The revenue from medical beauty treatment services reached 144 million yuan, reflecting a year-on-year growth rate of 426.1% [1]. Business Expansion - The number of medical beauty clinics under the light medical beauty chain brand "Xinyang Youth Clinic" has increased to 33 [1]. - The company's Chairman and CEO, Jin Xing, stated that there will be an increased density of Xinyang Youth Clinics in major cities such as Beijing and Guangzhou, with an expectation to reach 50 clinics by the end of the year [1].

Financial Data and Key Metrics Changes - Total revenue for Q2 was RMB 379 million, a decrease of 7% year over year, primarily due to a decline in medical service providers subscribing to information services [15] - Aesthetic treatment service revenues reached RMB 144 million, an increase of 426% year over year, exceeding guidance [15] - Net loss attributable to the company was RMB 36 million, compared to a net income of RMB 18.9 million in the same period last year [19] - Non-GAAP net loss was RMB 30.5 million, compared to a non-GAAP net income of RMB 22.2 million in the same period of 2024 [19] - Basic and diluted losses per ADS were RMB 0.35, compared to earnings of RMB 0.18 in the same period last year [19] Business Line Data and Key Metrics Changes - Revenue from aesthetics center business reached RMB 144 million, marking it as the largest revenue segment for the first time [4] - Aesthetic treatment services revenue increased by 46% quarter over quarter and 426% year over year [5] - Total number of verified treatment visits surpassed 67,400 in Q2, up 24% quarter over quarter and 381% year over year [7] - The overall repeat purchase rate for the aesthetic center business exceeded 60% [7] Market Data and Key Metrics Changes - The light medical aesthetic market in China is expected to reach around RMB 26 billion by 2030, with a penetration rate forecasted to reach 30% [30] - The company aims to achieve a market share of roughly 25% in the light medical aesthetic sector [30] Company Strategy and Development Direction - The company plans to open around 10 aesthetic centers in the third quarter, targeting a total of 50 centers by year-end [11] - The focus is on expanding in both first-tier and core second-tier cities, enhancing accessibility to medical aesthetic services [11] - The company is committed to optimizing user experience and operational efficiency to strengthen its competitive edge [13] Management Comments on Operating Environment and Future Outlook - Management remains optimistic about the growth potential of China's medical aesthetic market, citing a current penetration rate below 5% [30] - The company expects aesthetic treatment service revenues to be between RMB 150 million and RMB 170 million in the upcoming quarter, representing a significant increase from the same period in 2024 [20] - The company emphasizes the importance of sustainable low-cost customer acquisition and a diversified upstream supply chain [31] Other Important Information - The company has maintained a robust cash position with cash and cash equivalents totaling RMB 98.6 million as of June 30, 2025 [20] - The gross profit margin for aesthetic treatment services expanded by around five percentage points sequentially [8] Q&A Session Summary Question: Expansion plan for C and I payment and franchise model - The company aims to grow the number of centers to 50 by the end of this year, with plans for more than 10 openings in the second half [24] - Long-term, the target is to achieve 1,000 centers within eight to ten years, with franchising being a future focus [25][26] Question: Growth potential of the Chinese medical aesthetics market - Management is optimistic about the market, with substantial growth potential indicated by a low current penetration rate [30] - The company plans to focus on three core capabilities to maintain its competitive edge [31] Question: Outlook for customer acquisition cost and marketing expenses - The average customer acquisition cost remains low, with over 70% of new customers coming from referrals [34] - The company plans to enhance brand visibility through localized marketing initiatives [34] Question: Recruitment of doctors and reliance on center managers - There is a solid base for recruiting doctors, with many moving from public hospitals to the medical aesthetic sector [40] - The company operates on a model that reduces reliance on center managers, improving operational efficiency [42] Question: Differentiation in product strategy - The product strategy focuses on anti-aging treatments, ensuring consistency and overall cost-effectiveness across the portfolio [46] - The company aims to optimize its product portfolio based on market demand and competitive trends [48] Question: Updates on the POP business - The POP business remains a key pillar of profitability, with plans to promote synergies between POP and aesthetic center businesses [50]

Core Viewpoint - New Oxygen aims to become a disruptor in the medical beauty industry by launching its own light medical beauty brand, "New Oxygen Youth Clinic," to create a "high quality, low price" model in response to the changing consumer demographics and market dynamics [1][2][3] Company Strategy - New Oxygen has transitioned from being a medical beauty e-commerce platform to establishing its own light medical beauty clinics, targeting a broader consumer base beyond high-net-worth individuals [2][3] - The company plans to integrate and optimize its supply chain to lower costs and enhance service quality, addressing consumer pain points related to high prices and inconsistent treatment quality [3][8] Market Dynamics - The light medical beauty market in China reached a scale of 1,461 billion yuan in 2023, accounting for 80.8% of total medical beauty consumption, with a year-on-year growth of 5.8% [7] - The market is expected to grow to 4,157 billion yuan by 2030, nearly double that of surgical medical beauty [7] Financial Performance - New Oxygen's light medical beauty chain business reported a revenue increase of 551.4% year-on-year to 98.88 million yuan in Q1 2025, contributing 33.3% to total revenue [3] - The company anticipates its medical treatment service revenue to reach 120-140 million yuan in Q2 2024, representing a year-on-year growth of 337%-410% [3] Competitive Landscape - New Oxygen's pricing strategy has led to friction with upstream manufacturers over pricing authority, highlighting a shift in market dynamics where pricing should be determined by supply and demand rather than manufacturer control [5][6] - The company has made strategic acquisitions to strengthen its position in the upstream medical beauty market, including a significant investment in a medical device company [7][8] Industry Challenges - The medical beauty industry faces challenges such as declining profits and increasing scrutiny from regulators, necessitating a transformation in business models and practices [3][11] - New Oxygen aims to address safety and quality concerns in the industry by ensuring rigorous training for its medical staff and maintaining high operational standards [10][12] Future Outlook - The industry is expected to evolve towards a model where professional doctors operate clinics, ensuring safety and quality, alongside large chain institutions like New Oxygen Youth Clinic [11][13] - The company envisions a future where transparent pricing and service quality will become the norm, making light medical beauty accessible to a wider audience [12][13]

Core Viewpoint - New Oxygen aims to become a disruptor in the medical beauty industry by launching its own light medical beauty brand, New Oxygen Youth Clinic, to create a "high quality, low price" model in response to the market shift towards a broader consumer base [1][5][14] Group 1: Company Strategy - New Oxygen officially launched its light medical beauty brand, New Oxygen Youth Clinic, in November 2024, promoting it as an affordable option for consumers [4][5] - The company is transitioning from being a medical beauty e-commerce platform to establishing physical clinics, aiming to integrate and optimize the entire service chain to enhance quality and reduce costs [5][9] - New Oxygen's light medical beauty projects include various services priced from hundreds to thousands of yuan, targeting a wider audience beyond high-net-worth individuals [4][8] Group 2: Market Context - The light medical beauty market in China reached a scale of 1,461 billion yuan in 2023, accounting for 80.8% of the total medical beauty consumption, with a year-on-year growth of 5.8% [8] - The traditional high-price model in the medical beauty industry is becoming unsustainable, leading to a demand for more affordable options as the consumer base shifts to the general public [5][8][14] Group 3: Competitive Dynamics - New Oxygen's pricing strategy has led to conflicts with upstream manufacturers over pricing authority, particularly highlighted by the controversy surrounding the pricing of the "Miracle Youth" project [7][9] - The company has made strategic acquisitions to strengthen its position in the upstream market, including a significant investment in medical device companies [9][10] Group 4: Industry Trends - The medical beauty industry is experiencing a shift towards more standardized and regulated practices, with a growing emphasis on safety and quality as consumer awareness increases [10][12] - The future of the industry is expected to see a rise in both professional doctor-operated clinics and large chain medical beauty institutions like New Oxygen Youth Clinic, promoting a more organized market [12][15]

Core Insights - The 2025 medical beauty industry is expected to show diverse development trends, with various segments demonstrating distinct characteristics [1][5] - Light medical beauty is becoming mainstream due to its minimal trauma, quick recovery, and low risk, attracting many first-time consumers [1][8] - The male medical beauty market is rapidly growing, with 73% of men planning to increase their spending in 2024, focusing on anti-aging and minor adjustments [1][23] - Cross-border medical beauty is booming, with South Korea and Hong Kong being the preferred destinations, accounting for 62% and 45% respectively [1][37] Group 1: Light Medical Beauty - Light medical beauty accounts for 44% in injection and 47% in phototherapy, with a projected compound annual growth rate (CAGR) of 20%-30% over the next five years [1][11] - The primary demographic for light medical beauty is women, making up 89% of the interest group, with 37.5% aged 25-29 [1][14] - Popular procedures include water light needles and photon rejuvenation, with compliance, safety, and efficacy being key consumer concerns [1][18] Group 2: Male Medical Beauty - The male medical beauty market is identified as the "second curve" of industry growth, with significant interest in anti-aging and minor adjustments [1][23] - Social media and workplace scenarios are major drivers for male consumers, with core concerns including nasolabial folds and tear troughs [1][29] - 43% of men plan to increase their medical beauty spending in 2024, indicating a shift in consumer behavior [1][25] Group 3: Cross-Border Medical Beauty - The demand for cross-border medical beauty is projected to reach 26% by 2025, with high cost-effectiveness and professionalism being the main attractions [1][37] - However, concerns about language barriers and difficulties in rights protection remain significant [1][37] Group 4: Youth and Medical Beauty - High school graduates are emerging as a significant consumer group during the summer, with a 245% increase in discussions around "post-exam medical beauty" [2][5] - Popular procedures among this demographic include double eyelid surgery and phototherapy, driven by aesthetic recognition and social media influence [2][5] Group 5: Cross-Industry Integration - Beauty and cosmetics companies are increasingly entering the medical beauty sector, with medical-grade dressings becoming popular entry products [2][5] - The medical device auxiliary market is expected to reach 25.38 billion yuan by 2026, with a CAGR of 30% [2][5]